Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,014 | 71,286 | 119,709 | 209,948 | 684,636 |
| Marketable Securities | 513,473 | 639,355 | 825,283 | 267,166 | 187,213 |
| Receivables | 77,609 | 43,178 | 36,938 | 37,030 | 25,309 |
| Inventories | 13,611 | 21,223 | 29,697 | 21,817 | 8,581 |
| TOTAL | $742,678 | $808,393 | $1,046,651 | $554,025 | $927,759 |
| Non-Current Assets | |||||
| PPE Net | 36,593 | 41,959 | 33,344 | 30,700 | 34,129 |
| Investments And Advances | 277,149 | 84,319 | 161,269 | 557,529 | 677,873 |
| Other Non-Current Assets | 123,393 | 114,579 | 108,638 | 109,971 | 78,632 |
| TOTAL | $437,135 | $240,857 | $303,251 | $698,200 | $790,634 |
| Total Assets | $1,179,813 | $1,049,250 | $1,349,902 | $1,252,225 | $1,718,393 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 43,917 | 30,278 | 16,851 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,790 | 4,710 | 2,729 | 8,333 | 4,370 |
| Accrued Expenses | 133,088 | 127,992 | 131,123 | 121,829 | 105,938 |
| Other current liabilities | 61,650 | 39,198 | 17,285 | N/A | N/A |
| TOTAL | $260,796 | $214,923 | $183,234 | $149,765 | $130,802 |
| Non-Current Liabilities | |||||
| Long Term Debt | 343,053 | 208,535 | 122,232 | N/A | N/A |
| Deferred Revenues | 2,005 | 812 | 4,667 | 11,510 | 12,559 |
| Other Non-Current Liabilities | 269,106 | 490,391 | 516,135 | 106,659 | 88,904 |
| TOTAL | $620,352 | $703,718 | $651,991 | $131,725 | $117,503 |
| Total Liabilities | $881,148 | $918,641 | $835,225 | $281,490 | $248,305 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,906 | 61,232 | 59,984 | 59,203 | 57,958 |
| Common Shares | 64 | 61 | 60 | 59 | 58 |
| Retained earnings | -2,407,031 | -2,339,942 | -1,832,958 | -1,275,441 | -631,356 |
| Other shareholders' equity | -3,551 | -3,495 | -10,443 | -4,133 | -5,214 |
| TOTAL | $298,665 | $130,609 | $514,677 | $970,735 | $1,470,088 |
| Total Liabilities And Equity | $1,179,813 | $1,049,250 | $1,349,902 | $1,252,225 | $1,718,393 |